Krsnaa Diagnostics Schedules Q4FY26/FY26 Earnings Conference Call for May 26, 2026
Krsnaa Diagnostics will hold its Q4FY26/FY26 earnings conference call on May 26, 2026, at 12:30 PM IST. Management, including Chairman Mr. Rajendra Mutha and MD Mr. Yash Mutha, will participate. Dial-in details and registration links are provided. Transcript and audio will be uploaded post-call.
This is a standard post-earnings communication for investors and analysts. It does not introduce new material information that would significantly impact the company's stock price or business operations.
The announcement is a routine disclosure regarding a scheduled investor call to discuss financial results. It does not contain any new financial information or strategic decisions that would sway sentiment.
Krsnaa Diagnostics Limited has announced updates regarding its post-earnings conference call for Q4FY26 and FY26 results. The call is scheduled to take place on Tuesday, May 26, 2026, at 12:30 PM Indian Standard Time. Key management personnel participating in the call include Mr. Rajendra Mutha (Chairman & Whole-time Director), Mr. Yash Mutha (Managing Director), Mr. Mitesh Dave (Group CEO), Mr. Chandra Prakash Singh (Interim CFO), and Mr. Sujoy Bose (Head - Secretarial, Legal and Compliance).
The company has provided a Diamond Pass registration link for participants to join the call and has also shared universal access dial-in numbers for India (+91 22 6280 1224 / +91 22 7115 8125) and international toll-free numbers for the USA, UK, Singapore, and Hong Kong. Following the call, the transcript and audio link will be made available on the company's investor website, www.krsnaadiagnostics.com/investors.
Equirus Securities is facilitating this conference call. For further information, interested parties can contact Bharat Celly or Vinay Jain from Equirus Securities, or Sujoy Bose from Krsnaa Diagnostics Limited.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.